Disorders of the Pleura III: Chronic Empyema

Author: Paul Schipper, MD
Institution: OHSU
Date Reviewed: June 2025
Original Case: Fawwaz Shaw, MD / University of Washington
Learning Domain: General Thoracic
Learning Objective: Management principles of Chronic Empyema
PowerPoint File: Disorders of the Pleura III: Chronic Empyema

 

Discussion Points

  • Adequacy of Initial Therapy?
  • Impact of COPD / Chronic Renal Failure
  • If  / When to operate?
  • Operative Options?
  • Pleural space management?
  • Adjunctive support: nutrition / rehab

 

Etiologies of Empyema

  • Sources contiguous with pleura (50-60%): 
    • Lung, mediastinum, deep cervical, chest wall, spine, and subphrenic space.
  • Hematogenous spread (15%).
  • Direct innoculation of pleural space (30-40%):
    • Minor thoracic interventions, post-op infections, penetrating trauma.

 

Stages of Empyema

StagesCharacteristics
Exudative (acute)Pleural space is contiguous.
No loculations/septations.
Fibrinopurulent (Transitional)Several days-weeks.
Loculations with thin fibrous septae.
Organizing (Chronic)Thick fibrinous peel.
Traps the lungs.

 

Management Options

StagesManagement
Exudative (acute)Chest tube + Antibiotics.
Fibrinopurulent (transitional)VATS decortication.
Organized (Chronic)Thoracotomy and decortication.
  • Principle is to effectively manage the pleural space based on the stage of empyema.
  • Is there a role for fibrinolytics?
  • High (>45%) failure rate with fibrinolytics. May have utility in early – transitional phase of empyemas.

 

What if an infected pleural space remains?

  • Eloesser flap
  • Clagett procedure : open pleural drainage, serial debridement and irrigation with antibiotic irrigation, followed by chest closure once pleural space “sterilized”.
  • Muscle transpositions / omentum to obliterate pleural space
  • Thoracoplasty (mostly historical)